Product Details
| Product Name: Lanreotide Acetate | CAS No.: 127984-74-1 |
| Min. Order: 1kg | Purity: 99% |
| Supply Ability: 100kg | Release date: 2026/04/17 |
| Lead time: in stock | Packaging: bag/bottle/drum//IBC, as request |
| Delivery: By sea, by air, by express | Origin: Manufacturer |
| Name: Tina |
PRODUCT INFORMATION
| Name | Somatuline |
|---|---|
| Synonym | More Synonyms |
| Molecular Formula | C56H73N11O12S2 |
|---|---|
| Molecular Weight | 1156.375 |
| Exact Mass | 1155.488159 |
| Appearance of Characters | white to off-white |
| Storage condition | ?20°C |
| Symbol |  GHS08 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H361 |
| Precautionary Statements | P281 |
| Hazard Codes | Xn |
| Risk Phrases | 63 |
| Safety Phrases | 36/37 |
| RIDADR | NONH for all modes of transport |
| [Drug therapy for acromegaly]. Orv. Hetil. 154(39) , 1527-34, (2013) Prolonged overproduction of growth hormone, like insulin-like growth factor-1 hypersecretion leads to acromegaly in adults. This is associated with several co-morbidities and increased mortality. Desp... | |
| Real-world comorbidities and treatment patterns of patients with acromegaly in two large US health plan databases. Pituitary 16(3) , 354-62, (2013) Acromegaly is a rare, chronic, and debilitating disease that results from excessive growth hormone production. Clinically, this disease is associated with enlargement of soft tissue, excessive skeleta... | |
| Control of disease activity and tumor size after introduction of pegvisomant in a lanreotide-resistant acromegalic patient. Ann. Endocrinol. (Paris.) 74(1) , 49-52, (2013) We report on a 30-year-old female acromegalic patient treated with the growth hormone (GH) receptor antagonist pegvisomant at a low dose after the failure of long-acting lanreotide, neurosurgery and r... |
| (4R,7S,10S,13R,16S,19R)-10-(4-Aminobutyl)-N-[(2S,3R)-1-amino-3-hydroxy-1-oxo-2-butanyl]-16-(4-hydroxybenzyl)-13-(1H-indol-3-ylmethyl)-7-isopropyl-19-{[3-(2-naphthyl)-D-alanyl]amino}-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide acetate (1:1) |
| 9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide acetate (salt) |
| 1,2-Dithia-5,8,11,14,17-pentaazacycloeicosane-4-carboxamide, 10-(4-aminobutyl)-N-[(1S,2R)-1-(aminocarbonyl)-2-hydroxypropyl]-19-[[(2R)-2-amino-3-(2-naphthalenyl)-1-oxopropyl]amino]-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-7-(1-methylethyl)-6,9,12,15,18-pentaoxo-, (4R,7S,10S,13R,16S,19R)-, acetate (1:1) (salt) |
| Somatuline |
| (4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-19-{[(2R)-2-amino-3-naphthalen-2-ylpropanoyl]amino}-N-[(1S,2R)-1-carbamoyl-2-hydroxypropyl]-16-(4-hydroxybenzyl)-13-(1H-indol-3-ylmethyl)-7-(1-methylethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide acetate (salt) |
| 9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-carboxamidacetat(salt) |
| (4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-N-[(1S,2R)-1-carbamoyl-2-hydroxypropyl]-16-(4-hydroxybenzyl)-13-(1H-indol-3-ylmethyl)-7-(1-methylethyl)-19-[(3-naphthalen-2-yl-D-alanyl)amino]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide acetate (salt) |
| Somatuline LP |
| (4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-N-[(1S,2R)-1-carbamoyl-2-hydroxypropyl]-16-(4-hydroxybenzyl)-13-(1H-indol-3-ylmethyl)-7-(1-methylethyl)-19-[(3-naphthalen-2-yl-D-alanyl)amino]-6,9,12,15,18-pe |
| lanreotide acetate |
| (4R,7S,10S,13R,16S,19R)-10-(4-Aminobutyl)-19-{[(2R)-2-amino-3-naphthalen-2-ylpropanoyl]amino}-N-[(1S,2R)-1-carbamoyl-2-hydroxypropyl]-16-(4-hydroxybenzyl)-13-(1H-indol-3-ylmethyl)-7-(1-methylethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-carboxamidacetat(salt) |
| (4R,7S,10S,13R,16S,19R)-10-(4-Aminobutyl)-19-{[(2R)-2-amino-3-naphthalen-2-ylpropanoyl]amino}-N-[(1S,2R)-1-carbamoyl-2-hydroxypropyl]-16-(4-hydroxybenzyl)-13-(1H-indol-3-ylmethyl)-7-(1-methylethyl)-6, |
| Somatuline LA |
| ntaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide acetate (salt) |
| Somatuline Autogel |
| 1,2-dithia-5,8,11,14,17-pentaazacycloeicosane-4-carboxamide, 10-(4-aminobutyl)-N-[(1S,2R)-1-(aminocarbonyl)-2-hydroxypropyl]-19-[[(2R)-2-amino-3-(2-naphthalenyl)-1-oxopropyl]amino]-16-[(4-hydroxypheny |
Company Profile
Our company is a high-tech enterprise specializing in chemical raw materials such as electronic materials, optoelectronic materials, semiconductor materials, UV monomers, silane catalysts, cosmetic raw materials, etc. The company integrates research and development, production, customized synthesis, and sales, and is committed to providing customers with high-quality chemical product solutions.
Our Company
Our Advantage
Rich experience
Our products have been exported to many countries, including Germany, Spain, the United Kingdom, the United States, Australia, the Middle East, Asia, and more. We have received highly positive feedback from our clients and have established long-term friendly cooperative relationships with them.
Excellent quality, purity, and competitive price
Excellent quality is one of the cornerstones of our success. We welcome ordering samples for quality testing.
Safe and fast delivery
We will arrange shipment of spot products as soon as we receive payment.
Customized products are determined based on the synthesis time of different products.
Excellent pre-sales and after-sales service
Pre sales:
We are committed to providing the most favorable quotes and detailed information about our products and company.
after-sale service:
We assist buyers in customs clearance by providing necessary documents and information.
If there is any dispute over product quality, we are committed to providing the best solution.
? Packaging:
1kg/bag, 25kg/drum, 50kg/drum, 180kg/drum, 200kg/drum, 1T/bag/drum, standard export packaging or packaging required by customers
? Shipping
? Delivery:
Within 7 days after receiving your payment
Contact information
For more details, pls contact us freely.
Contact name: Tina
Email address: Tina@fdachem.com
Mob: 86 13213167925
WhatsApp/Skype/Wechat/LINE: 86 15225627621
Company Profile Introduction
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $1.00 |
VIP6Y
|
RongNa Biotechnology Co.,Ltd
|
2026-06-30 | |
|
VIP1Y
|
Jinan Ruitong Biotech Co., Ltd.
|
2026-06-08 | ||
| $1000.00 |
VIP1Y
|
Chengdu Shengnuo Biopharm Co.,Ltd
|
2026-05-28 | |
| $70.00 |
VIP3Y
|
Zibo Hangyu Biotechnology Development Co., Ltd
|
2026-05-05 | |
|
Shanghai Affida new material science and technology center
|
2025-01-06 | |||
| $286.00 |
Hebei Anlijie Biotechnology Co., Ltd
|
2024-08-15 | ||
|
Hebei Xinsheng New Material Technology Co., LTD.
|
2023-08-25 | |||
| $3.00 |
VIP8Y
|
Career Henan Chemical Co
|
2019-07-12 | |
| $35.00 |
Hebei Xinsheng New Material Technology Co., LTD.
|
2023-08-25 |
China